Healthcare - Medical - Diagnostics & Research - NASDAQ - DE
$ 0.2387
-4.52 %
$ 5.22 M
Market Cap
-0.22
P/E
CASH FLOW STATEMENT
-21.9 M
OPERATING CASH FLOW
-1.9 M
INVESTING CASH FLOW
14.2 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Mainz Biomed B.V.
| Net Income | -26.3 M |
| Depreciation & Amortization | 866 K |
| Capital Expenditures | -1.9 M |
| Stock-Based Compensation | 4.01 M |
| Change in Working Capital | -64.6 K |
| Others | -751 K |
| Free Cash Flow | -23.8 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (26.3) | (26.4) | (11.7) | (0.6) | (1.0) |
| Depreciation & Amortization | 0.9 | 0.4 | 69.9 K | 60.5 K | 53 K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 4.0 | 9.8 | 6.4 | 0 | 0 |
| Other Operating Activities | (0.5) | 26.8 K | 2.1 | 107 | 64.5 K |
| Change in Working Capital | 64.6 K | 1.4 | (0.1) | 57.6 K | 0.4 |
| Cash From Operations | (21.9) | (14.8) | (3.2) | (0.5) | (0.4) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (1.9) | (0.7) | 16.7 K | 9.68 K | 0 |
| Other Items | 0 | 0 | 1.2 | 0 | 0 |
| Cash From Investing Activities | (1.9) | (0.7) | 1.2 | 9.68 K | 0 |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 7.8 | (0.2) | 0.2 | 0.4 | 0.4 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0.3 | 0 | 25.3 K | 0 |
| Cash From Financing Activities | 14.2 | 23.9 | 10.6 | 0.4 | 0.4 |
| CHANGE IN CASH | |||||
| Net Change In Cash | (10.1) | 8.4 | 8.6 | 81 K | 25.9 K |
| FREE CASH FLOW | |||||
| Free Cash Flow | (23.8) | (15.4) | (3.2) | (0.5) | (0.4) |